SCARA5 and lung carcinoma: Although few samples had mutations in PBK, we observed that mutations in CNV accounted for the majority of PBK gene DNA alterations in all lung cancer patients and found a high proportion of LUAD patients with CNV with multiple tumor suppressor genes, such as CCDC25, SCARA5 and EPHX2 (Fig. 3E).